Dr. Carlos del Río, Professor of Medicine and Global Health at Emory University, explains why it is good for laboratories that develop a vaccine against covid-19 to stop testing in phase 3, when a possible medical problem is detected in some patient.
Why is it good for laboratories to stop a possible vaccine against covid-19? | Video | CNN
2020-10-14T02:21:47.088Z
Dr. Carlos del Río, Professor of Medicine and Global Health at Emory University, explains why it is good for laboratories that develop a | Latin America | CNN
Similar news:
- Pfizer plans to have a vaccine against covid-19 in Mexico by the end of 2020 | Video | CNN 4 years
- This is how the development of vaccines against covid-19 is in phase 3 | CNN 4 years
- Panama begins phase 2 of a clinical study of a vaccine against covid-19 | Video | CNN 4 years
- Government of Mexico signs agreement with 3 pharmaceutical companies for the purchase of vaccine against covid-19 | Video | CNN 4 years
- Russia registers a second vaccine against covid-19 | Video | CNN 4 years
- Experimental vaccine against covid-19 will be tested in 12-year-old children | Video | CNN 4 years
- Europe strengthens measures against covid-19 | Video | CNN 4 years